Table 4.
Studies showing factors predicting poor survival after hepatic resection for non-colorectal non-neuroendocrine metastatic tumours
| Authors | Year | No. of patients | 5-year survival | Poor prognostic factors |
|---|---|---|---|---|
| Schmelzle M21 | 2010 | 44 | 20% | Lack of chemotherapy Adenocarcinoma DFI < 18 months |
| Ercolani G22 | 2009 | 134 | 40% | Tumour > 5 cm DFI < 12 months Gastrointestinal primary |
| Lehner F23 | 2009 | 242 | 28% | R0 resection Synchronous tumours |
| O'Rourke TR20 | 2007 | 102 | 38% | Tumour > 5 cm Extrahepatic nodal disease |
| Lendoire J24 | 2007 | 106 | 19% | Non-genitourinary primary Non-breast primary R1 resection Synchronous tumours |
| Adam R19 | 2006 | 1452 | 36% | Age > 60 years Non-breast primary Melanoma/squamous tumours DFI < 12 months Extrahepatic disease R2 resection Major hepatectomy |
| Reddy SK25 | 2006 | 82 | 37% | No adjuvant chemoradiotherapy Diagnosis to resection < 6 months |
| Earle26 | 2006 | 69 | 30.5% | Tumour type DFISynchronous tumours |
| Weitz J17 | 2005 | 141 | 17% | Non-genital primary R1 resection DFI < 2 years |
| Laurent C27 | 2001 | 39 | 35% | DFI < 24 months |
DFI, disease-free interval.